Combating Illicit Xylazine Act
Legislative Progress
Introduced
February 12, 2025
Latest Action
April 15, 2026
Primary Sponsor
Catherine Cortez MastoDemocratic(NV)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
427d open
vs 5,674 other S bills in the 119th — cohort avg 32d
Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused. Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA. The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs. The bill also exempts xylazine manufacturers from the CSA's physical security requirements. Finally, the bill requires the DEA, in coordination with the Department of Health and Human Services (HHS), to provide Congress with a report on how the agencies previously determined whether xylazine should be a controlled substance, including the full text of HHS's recommendations to the DEA for scheduling xylazine.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (8)
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Law Enforcement/Crime/Criminal Justice
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Client expense: $5,490 · Firm income: Not reported
2026 · third_quarter · Alcohol and Drug Abuse
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communities Act (H.R. 2194); Protecting First Responders from Secondary Exposure Act of 2025 (H.R. 621 / S. 180); Marc Fischer Memorial Act (H.R. 1046 / S. 1295).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Law Enforcement/Crime/Criminal Justice
S. 4784, the FY 2027 National Defense Authorization Act, a bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, and to prescribe military personnel strengths for such fiscal year; S. Amdt. 6016, "Safer Streets and Communities"; S. Amdt. 6468, to add Subtitle H, "Judiciary Matters"; S. Amdt. 5998, "Public Safety Officers' Benefit Program Expansion"; S. Amdt. 6444, "Fighting PTSD"; and S. Amdt. 6446, "Improving Law Enforcement Officer Safety and Wellness Through Data Act." H.R. 10269, the "Stop Auto Fraud Act," a bill to amend title 18 to include an offense for motor vehicle collision fraud; entire bill. H.R. 1266, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 545, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Pharmacy
Combating Illicit Xylazine Act (HR1266/S545). Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM. Anticipated House and Senate versions of the Animal Drug User Fee Act & Animal Generic Drug User Fee Act.
Client expense: $200,712 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · third_quarter · Law Enforcement/Crime/Criminal Justice
Cannabis Administration and Opportunity Act (CAOA) (S. 5022); Cashless Bail Reporting Act (H.R. 5625); Combating Illicit Xylazine Act (S. 545/H.R. 1266); Combating Organized Retail Crime Act (CORCA) (S. 1404/H.R. 2853); Continuing Appropriations / temporary funding extension (H.R. 6500); District of Columbia Cash Bail Reform Act (S. 2706/H.R. 5214); Federal Carjacking Enforcement Act (S. 1572/H.R. 6155); James T. Woods Act (H.R. 6719); Kayleigh's Law (S. 5372/H.R. 8481); National Defense Authorization Act (NDAA) (S. 4784/H.R. 8800); No Bailouts Act (H.R. 8821); STOP CSAM Act (S. 1829); STOP Nitazenes Act (H.R. 7970); Stop Pills That Kill Act (S. 3087/H.R. 8005); Right to Trial Act (H.R. 9095); Prohibiting Punishment of Acquitted Conduct Act (S. 3483); 702 reauthorization
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2026 · second_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the Count the Crimes to Cut Act, H.R. 2159; supporting the Quality Defense Act, S.1102; supporting the EQUAL Act; supporting the Fresh Start Act (H.R. 3111 / S.2590); supporting the Clean Slate Act (H.R. 3114 / S.1580); supporting the FAIR Act, S.263; supporting the Kenneth P. Thompson Begin Again Act; supporting the Safer Supervision Act (H.R. 5883 / S. 3077); supporting the Safer Detention Act (S.3485); supporting the Prohibiting Punishment of Acquitted Conduct Act (S.3483); supporting the First Step Implementation Act (S. 3482); supporting Second Chance Reauthorization Act of 2025 (H.R. 3552 / S. 1843); supporting the SEEK Help Act; opposing the repeal of the Second Chance Amendment Act of 2022 and the Incarceration Reduction Amendment Act of 2016 (H.R. 5242); supporting USSC amendments to supervised release and the crack-powder cocaine sentencing disparity; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight Act; supporting the Mens Rea Reform Act (H.R.59); supporting reforms to the Prison Rape Elimination Act; opposing significant funding cuts to the Government Accountability Office (GAO); supporting the Inspector General Access Act; opposing the DC Juvenile Sentencing Reform Act (H.R. 5140); supporting the FIX Clemency Act; supporting the ED ACCESS Act; opposing the Nitazene Control Act (H.R. 5415 /S. 3076) and STOP Nitazenes Act (H.R. 7970); opposing the Keep Violent Criminals Off Our Streets Act (H.R. 6260), and supporting legislation to reform the Armed Career Criminals Act.
2026 · second_quarter · Alcohol and Drug Abuse
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communities Act (H.R. 2194); Protecting First Responders from Secondary Exposure Act of 2025 (H.R. 621 / S. 180); Marc Fischer Memorial Act (H.R. 1046 / S. 1295).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Pharmacy
Combating Illicit Xylazine Act (HR1266/S545). Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM. Anticipated House and Senate versions of the Animal Drug User Fee Act & Animal Generic Drug User Fee Act.
Client expense: $214,422 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2026 · second_quarter · Law Enforcement/Crime/Criminal Justice
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to support and co-sponsor the Cannabis Administration and Opportunity Act in the Senate. We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Client expense: $18,639 · Firm income: Not reported
2026 · second_quarter · Law Enforcement/Crime/Criminal Justice
Combatting Illicit Xylazine Act (H.R. 1266, S. 545); Federal Carjacking Enforcement Act (H.R. 6155, S. 1572); Make the District of Columbia Safe and Beautiful Act of 2025 (H.R. 5103); Combating Organized Retail Crime Act (CORCA) (H.R. 2853, S. 1404); Cashless Bail Reporting Act (H.R. 5625); Keeping Violent Offenders Off Our Streets Act of 2025 (H.R. 6260); Cannabis Administration and Opportunity Act (CAOA); Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R. 5068); FY2027 funding for federal criminal defense; STOP Nitazenes Act (H.R. 7970); DOJ Proposed Rule (3/16) on Chapter 154 certification; Right to Trial Act (H.R. 9095); Prohibiting Punishment of Acquitted Conduct Act (S. 3483); 702 reauthorization; email privacy act; mail cover surveillance bill (not yet introduced); Combating Organized Retail Crime Act of 2025 (H.R. 2853); NDAA
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2026 · second_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 2243, the "LEOSA Reform Act," legislation to amend title 18, United States Code, to improve the Law Enforcement Officers Safety Act of 2004 and provisions relating to the carrying of concealed weapons by law enforcement officers; entire bill. S. 679, the LEOSA Reform Act," legislation to amend title 18, United States Code, to improve the Law Enforcement Officers Safety Act of 2004 and provisions relating to the carrying of concealed weapons by law enforcement officers; entire bill. H.R. 378, the "Thin Blue Line Act," a bill to amend title 18, United States Code, to provide additional aggravating factors for the imposition of the death penalty based on the status of the victim; entire bill. H.R. 8845, the "Commerce, Justice, Science, and Related Agencies Appropriations Act," a bill making appropriations for the Departments of Commerce and Justice, Science, and Related Agencies for the fiscal year ending September 30, 2027; section 592, to prohibit law enforcement agencies from purchasing certain commercially available information that is used to generate investigative leads, identify threats, and locate victims during criminal investigations. S. 545, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 4784, the FY 2027 National Defense Authorization Act, a bill to authorize appropriations for fiscal year 2027 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, and to prescribe military personnel strengths for such fiscal year; S. Amdt. 5998, "Public Safety Officers' Benefit Program Expansion; S. Amdt. 6016, "Safer Streets and Communities"; S. Amdt. 6444, "Fighting Post-Traumatic Stress Disorder Act"; S. Amdt. 6446, "Improving Law Enforcement Officer Safety and Wellness through Data Act"; S. Amdt. 6468, to add Subtitle H--Judiciary Matters at the end of title X. Legislative proposals to reauthorize authorities under section 702 of the Foreign Intelligence Surveillance Act; amendment proposal to restrict law enforcement access to information that is critical to identifying public safety threats, locating victims, and solving crimes (no bill or amendment introduced). General education regarding the need for federal guidance and protections for state and local law enforcement with respect to assisting with federal immigration enforcement efforts.
2026 · first_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the Count the Crimes to Cut Act, H.R. 2159; supporting the Quality Defense Act, S.1102; supporting the EQUAL Act; supporting the Fresh Start Act (H.R. 3111 / S.2590); supporting the Clean Slate Act (H.R. 3114 / S.1580); supporting the FAIR Act, S.263; supporting the Kenneth P. Thompson Begin Again Act; supporting the Safer Supervision Act (H.R. 5883 / S. 3077); supporting the Safer Detention Act (S.3485); supporting the Prohibiting Punishment of Acquitted Conduct Act (S.3483); supporting the First Step Implementation Act (S. 3482); supporting Second Chance Reauthorization Act of 2025 (H.R. 3552 / S. 1843); supporting the SEEK Help Act; opposing the repeal of the Second Chance Amendment Act of 2022 and the Incarceration Reduction Amendment Act of 2016 (H.R. 5242); supporting USSC amendments to supervised release and the crack-powder cocaine sentencing disparity; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight Act; supporting the Mens Rea Reform Act (H.R.59); supporting reforms to the Prison Rape Elimination Act; opposing significant funding cuts to the Government Accountability Office (GAO); supporting the Inspector General Access Act; opposing the DC Juvenile Sentencing Reform Act (H.R. 5140); supporting the FIX Clemency Act; supporting the ED ACCESS Act; opposing the Nitazene Control Act (H.R. 5415 /S. 3076) and STOP Nitazenes Act (H.R. 7970); opposing the Keep Violent Criminals Off Our Streets Act (H.R. 6260), and supporting legislation to reform the Armed Career Criminals Act.
2026 · first_quarter · Law Enforcement/Crime/Criminal Justice
We urged Congress to support and co-sponsor the MORE Act (H.R. 5068). We urged Congress to oppose the Combating Xylazine Act(H.R. 1266/S. 545), Nitazene Control Act (H.R. 5415 /S. 3076), and STOP Nitazenes Act (H.R. 7970).
Client expense: Not reported · Firm income: Not reported
2026 · first_quarter · Alcohol and Drug Abuse
Combating Illicit Xylazine Act (H.R. 1266 / S. 545); Targeting Online Sales of Fentanyl Act (H.R. 5744); Combating Fentanyl Poisonings Act of 2025 (H.R. 5573); Ending Drug Trafficking in Our Communities Act (H.R. 2194); Protecting First Responders from Secondary Exposure Act of 2025 (H.R. 621 / S. 180); Marc Fischer Memorial Act (H.R. 1046 / S. 1295).
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Law Enforcement/Crime/Criminal Justice
H.R. 2243, the "LEOSA Reform Act," legislation to amend title 18, United States Code, to improve the Law Enforcement Officers Safety Act of 2004 and provisions relating to the carrying of concealed weapons by law enforcement officers; entire bill. H.R. 4310, the "Back the Blue Act," legislation to establish new criminal offenses for killing, assaulting, and fleeing to avoid prosecution for killing a judge, law enforcement officer, or public safety officer; expand the list of statutory aggravating factors in death penalty determinations to also include the killing or attempted killing of a law enforcement officer, judge, prosecutor, or firefighter or other first responder; and enact necessary reforms to the Law Enforcement Officers Safety Act of 2004; entire bill. S. 3366, the "Back the Blue Act," legislation to establish new criminal offenses for killing, assaulting, and fleeing to avoid prosecution for killing a judge, law enforcement officer, or public safety officer; expand the list of statutory aggravating factors in death penalty determinations to also include the killing or attempted killing of a law enforcement officer, judge, prosecutor, or firefighter or other first responder; and enact necessary reforms to the Law Enforcement Officers Safety Act of 2004; entire bill. H.R. 1266, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 545, the "Combatting Illicit Xylazine Act," a bill to prohibit certain uses of xylazine; entire bill. S. 167, the "Protect and Serve Act," a bill to amend title 18, United States Code, to punish criminal offenses targeting law enforcement officers; entire bill. H.R. 1551, the "Protect and Serve Act," a bill to amend title 18, United States Code, to punish criminal offenses targeting law enforcement officers; entire bill. H.R. 378, the "Thin Blue Line Act," a bill to amend title 18, United States Code, to provide additional aggravating factors for the imposition of the death penalty based on the status of the victim; entire bill. H.R. 2654, the "Lifesaving Gear for Police Act," a bill to prohibit the enforcement of certain regulations relating to sale, donation, and transfer of Federal Government property; entire bill. H.R. 7114, the "No Bounties on Badges Act," a bill to amend title 18, United States Code, to authorize awards for the arrest or conviction of individuals that deliberately target law enforcement officials with acts of violence or intimidation; entire bill.
2026 · first_quarter · Pharmacy
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
Client expense: $209,147 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Law Enforcement/Crime/Criminal Justice
Clean Slate Act (H.R. 3114, S. 1580); Marijuana Opportunity Reinvestment and Expungement (MORE) Act (H.R. 5068); Fresh Start Act (H.R. 3111); Second Chance Reauthorization Act (H.R. 3552, S. 1843); First Step Implementation Act; Safer Detention Act; Prohibiting Punishment of Acquitted Conduct Act; FY2027 funding for federal criminal defense; District of Columbia Cash Bail Reform Act (H.R. 5214); Safer Supervision Act (S. 3077); Smarter Pretrial Detention for Drug Charges Act (S. 3960); Combatting Illicit Xylazine Act(H.R. 1266, S. 545); STOP Nitazenes Act (H.R. 7970); FY2027 Commerce, Justice, Science and Related Agencies appropriations bill (mental health funding); Proposed amendments to the U.S. Sentencing Guidelines; Right to Trial Act; Mens Rea Reform Act of 2025 (H.R. 59); Count the Crimes to Cut Act (H.R. 2159); Prohibiting Punishment of Acquitted Conduct Act (S. 3483); 702 reauthorization, email privacy act, Effective Assistance of Counsel in the Digital Era Act, mail cover surveillance bill (not yet introduced)
Client expense: $15,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE
2025 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the Count the Crimes to Cut Act, H.R. 2159; supporting the Quality Defense Act, S.1102; supporting the EQUAL Act; supporting the Fresh Start Act (H.R. 3111 / S.2590); supporting the Clean Slate Act (H.R. 3114 / S.1580); supporting the FAIR Act, S.263; supporting the Kenneth P. Thompson Begin Again Act; supporting the Safer Supervision Act (H.R. 5883 / S. 3077); supporting the Safer Detention Act (S.3485); supporting the Prohibiting Punishment of Acquitted Conduct Act (S.3483); supporting the First Step Implementation Act (S. 3482); supporting Second Chance Reauthorization Act of 2025 (H.R. 3552 / S. 1843); supporting the SEEK Help Act; opposing the repeal of the Second Chance Amendment Act of 2022 and the Incarceration Reduction Amendment Act of 2016 (H.R. 5242); supporting USSC amendments to supervised release and the crack-powder cocaine sentencing disparity; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight Act; supporting the Mens Rea Reform Act (H.R.59); supporting reforms to the Prison Rape Elimination Act; opposing significant funding cuts to the Government Accountability Office (GAO); supporting the Inspector General Access Act; opposing the DC Juvenile Sentencing Reform Act (H.R. 5140); supporting the FIX Clemency Act; supporting the ED ACCESS Act; and supporting legislation to reform the Armed Career Criminals Act.
2025 · fourth_quarter · Law Enforcement/Crime/Criminal Justice
Issues relating to public safety, consent decree transparency, and nationwide standards; HELPER Act (S. 978, H.R. 2094); Honoring Our Fallen Heroes Act (S. 237, H.R. 1269); Law Enforcement Officer and Firefighter Recreation Pass Act (H.R. 183); National Law Enforcement Officers Remembrance, Support, and Community Outreach Act (H.R. 309); Reauthorizing Support and Treatment for Officers in Crisis Act (S. 419); First Responders Care Expansion (FRCE) Act; The Providing Child Care for Police Officers Act; Invest to Protect Act (S. 768, H.R. 2711); LEOSA Reform Act (S. 679, H.R. 2243); Prevent Family Fire Act (H.R. 169); Thin Blue Line Act (S. 83, H.R. 378); Protect and Serve Act (S. 167, H.R. 1551); HALT Fentanyl Act (S. 331, H.R. 27); Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting the Health and Safety of Law Enforcement Act; Crime Victims Fund Stabilization Act (H.R. 909); DRONE Act (H.R. 1058); Protecting First Responders from Secondary Exposure Act (S.180, H.R.621); Strong Communities Act of 2025 (S.1316, H.R.3458); Chief Herbert D. Proffitt Act (S.911, H.R.1236); PROTECT Our Children Reauthorization Act of 2025 (S.539, H.R.1274); Improving Police Critical Aid for Responding to Emergencies (CARE) Act (S.1595); Retired Law Enforcement Officers Continuing Service Act (S.1563, H.R.3846); Public Safety Officers' Benefits Program
Client expense: Not reported · Firm income: $50,000
2025 · fourth_quarter · Pharmacy
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
Client expense: $190,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Pharmacy
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
Client expense: $170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the Count the Crimes to Cut Act, H.R. 2159; supporting the Quality Defense Act, S.1102; supporting the EQUAL Act; supporting the Fresh Start Act (H.R. 3111 / S.2590); supporting the Clean Slate Act (H.R. 3114 / S.1580); supporting the FAIR Act, S.263; supporting the Kenneth P. Thompson Begin Again Act; supporting the Safer Supervision Act; supporting the SEEK Help Act; opposing the repeal of the Second Chance Amendment Act of 2022 and the Incarceration Reduction Amendment Act of 2016 (H.R. 5242); supporting USSC amendments to supervised release and the crack-powder cocaine sentencing disparity; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act (H.R. 27 / S. 331); opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act (H.R. 1266 / S.545); supporting the Due Process Continuity of Care Act (H.R.1510 / S.1720); supporting sufficient funding for the implementation of the Federal Prison Oversight Act; supporting the Mens Rea Reform Act (H.R.59); supporting reforms to the Prison Rape Elimination Act; opposing significant funding cuts to the Government Accountability Office (GAO); supporting the Inspector General Access Act; opposing the DC Juvenile Sentencing Reform Act (H.R. 5140); supporting the FIX Clemency Act; supporting the ED ACCESS Act; and supporting legislation to reform the Armed Career Criminals Act.
2025 · third_quarter · Animals
Rural Veterinary Workforce Act (HR 2398 and S 1163), Combating Illicit Xylazine Act (HR 1266 and S 545)
Client expense: $100,000 · Firm income: Not reported
Government targets: SENATE
2025 · third_quarter · Law Enforcement/Crime/Criminal Justice
Issues relating to public safety, consent decree transparency, and nationwide standards; HELPER Act (S. 978, H.R. 2094); Honoring Our Fallen Heroes Act (S. 237, H.R. 1269); Law Enforcement Officer and Firefighter Recreation Pass Act (H.R. 183); National Law Enforcement Officers Remembrance, Support, and Community Outreach Act (H.R. 309); Reauthorizing Support and Treatment for Officers in Crisis Act (S. 419); First Responders Care Expansion (FRCE) Act; The Providing Child Care for Police Officers Act; Invest to Protect Act (S. 768, H.R. 2711); LEOSA Reform Act (S. 679, H.R. 2243); Prevent Family Fire Act (H.R. 169); Thin Blue Line Act (S. 83, H.R. 378); Protect and Serve Act (S. 167, H.R. 1551); HALT Fentanyl Act (S. 331, H.R. 27); Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting the Health and Safety of Law Enforcement Act; Crime Victims Fund Stabilization Act (H.R. 909); DRONE Act (H.R. 1058); Protecting First Responders from Secondary Exposure Act (S.180, H.R.621); Strong Communities Act of 2025 (S.1316, H.R.3458); Chief Herbert D. Proffitt Act (S.911, H.R.1236); PROTECT Our Children Reauthorization Act of 2025 (S.539, H.R.1274); Improving Police Critical Aid for Responding to Emergencies (CARE) Act (S.1595); Retired Law Enforcement Officers Continuing Service Act (S.1563, H.R.3846); Public Safety Officers' Benefits Program
Client expense: Not reported · Firm income: $50,000
2025 · third_quarter · Pharmacy
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
Client expense: $170,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the Count the Crimes to Cut Act, H.R. 2159; supporting the Quality Defense Act, S.1102; supporting the EQUAL Act; supporting the Fresh Start Act (H.R. 3111); supporting the Clean Slate Act (H.R. 3114 / S.1580); supporting the FAIR Act, S.263; supporting the Kenneth P. Thompson Begin Again Act; supporting the Safer Supervision Act; supporting USSC amendments to supervised release and the crack-powder cocaine sentencing disparity; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act, H.R. 27 / S. 331; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act, H.R. 1266 / S.545; supporting the Due Process Continuity of Care Act, H.R.1510; supporting sufficient funding for the implementation of the Federal Prison Oversight Act; supporting the Mens Rea Reform Act (H.R.59); supporting reforms to the Prison Rape Elimination Act; opposing significant funding cuts to the Government Accountability Office (GAO); and supporting the Inspector General Access Act.
2025 · second_quarter · Law Enforcement/Crime/Criminal Justice
Issues relating to public safety, consent decree transparency, and nationwide standards; HELPER Act (S. 978, H.R. 2094); Honoring Our Fallen Heroes Act (S. 237, H.R. 1269); Law Enforcement Officer and Firefighter Recreation Pass Act (H.R. 183); National Law Enforcement Officers Remembrance, Support, and Community Outreach Act (H.R. 309); Reauthorizing Support and Treatment for Officers in Crisis Act (S. 419); First Responders Care Expansion (FRCE) Act; The Providing Child Care for Police Officers Act; Invest to Protect Act (S. 768, H.R. 2711); LEOSA Reform Act (S. 679, H.R. 2243); Prevent Family Fire Act (H.R. 169); Thin Blue Line Act (S. 83, H.R. 378); Protect and Serve Act (S. 167, H.R. 1551); HALT Fentanyl Act (S. 331, H.R. 27); Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting the Health and Safety of Law Enforcement Act; Crime Victims Fund Stabilization Act (H.R. 909); DRONE Act (H.R. 1058)
Client expense: Not reported · Firm income: $50,000
2025 · second_quarter · Pharmacy
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Law Enforcement/Crime/Criminal Justice
Supporting the Count the Crimes to Cut Act, H.R. 2159; supporting the Quality Defense Act, S.1102; supporting the EQUAL Act; supporting the Fresh Start Act; supporting the Clean Slate Act; supporting the FAIR Act, S.263; supporting the Kenneth P. Thompson Begin Again Act; supporting the Safer Supervision Act; supporting USSC amendments to supervised release and the crack-powder cocaine sentencing disparity; supporting adequate funding for public defenders; supporting ending the use of acquitted conduct in prison sentences for federal criminal offenses; supporting the expungement of federal simple possession drug offenses; supporting reforms to terms of supervised release after federal imprisonment; supporting federal sentencing reforms in general; supporting increased oversight of the Bureau of Prisons in general; supporting "second chances" for returning citizens in general; supporting increased and continued implementation of the First Step Act in general; supporting increased use of compassionate release, home confinement and other early release options; supporting prison reforms in general; supporting criminal discovery reforms in general; supporting the inclusion of well-defined terms and meaningful mens rea protections in all potential and existing federal criminal laws and regulations; supporting increased prosecutorial and policing accountability; supporting clemencies, commutations, and pardons; opposing the HALT Fentanyl Act, H.R. 27 / S. 331; opposing overcriminalization (creation of unnecessary federal criminal laws or regulations with poorly defined terms or weak mens rea protections or those that result in overly harsh incarcerative penalties) in general; opposing the Combating Illicit Xylazine Act, H.R. 1266 / S.545; and supporting the Due Process Continuity of Care Act, H.R.1510.
2025 · first_quarter · Animals
ASKED TO SUPPORT THE FOLLOWING: - Reintroduction of the Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act, which would increase funding to fight foreign animal disease and extend authorization for the Animal Health Protection Act through 2028. - H.R.2462, the Black Vulture Relief Act, which would allow livestock producers to take black vultures without a permit if the bird is causing death or injury to their animals. - H.R. 1897, the ESA Amendments Act, which would update the outdated ESA by establishing clear statutory definitions, focusing on species recovery, and streamlining the ESA permitting process. - S.574/H.R.1376, the Healthy Poultry Assistance and Indemnification Act, which would make all poultry growers and layer operations within a HPAI control area eligible to receive payments from APHIS compensation program, rather than only flocks that test positive. - Supported Secretary Rollins' February 2025 5 pronged approach to combat HPAI. - S.545/H.R.1266, the Combating Illicit Xylazine Act, which would schedule xylazine as a controlled substance. - H.R.845, the Pets and Livestock Protection Act, which would delist the gray wolf from the ESA to protect livestock. NEUTRAL/MONITORED BUT NOT LOBBIED BILLS: - H.R.1802, the Safeguard Pets, Animals, and Research Ethics (SPARE) Act, which would prohibit the use of animals in federally funded research, promote humane alternatives and promote ethical rehoming of retired research animals. MONARCH BUTTERFLY: - Reviewed FWS' proposal to list the Monarch Butterfly as an endangered species (Docket #: FWS-R3-ES-2024-0137-0001). - Expressed concerns to legislators over the impact this will have on agriculture. - Worked with PFB members to comply information for comments to FWS. - Attended monarch butterfly presentation at AFBF Convention. HPAI: - Had conversations with PA House and Senate offices over HPAI concerns - importance of biosecurity, education, proper compensation, preventative methods, etc. - Listened to USDA calls and other webinar addressing strategies to prevent HPAI OTHER: - Reviewed APHIS' final rule (89 FR 39194-39251) to make changes to the Horse Protection Act that would impact members involved in the equestrian industry. - Established a PA Federal Wildlife Coalition to address issues such as the ESA, Migratory Bird Treaty Act, etc. - Sent House Natural Resource's Water, Fish, and Wildlife subcommittee support letter for Endangered Species Amendments Act - Meeting with PA's APHIS Wildlife Services and PFB member regarding problems with depredation permit for predator birds - Conversations regarding protections against screwworm in Mexican cattle. Asked PA House offices to sign onto New World Screwworm letter by Rep. Gonzales.
2025 · first_quarter · Animals
ASKED TO SUPPORT THE FOLLOWING: - Reintroduction of the Foreign Animal Disease Prevention, Surveillance, and Rapid Response Act, which would increase funding to fight foreign animal disease and extend authorization for the Animal Health Protection Act through 2028. - H.R.2462, the Black Vulture Relief Act, which would allow livestock producers to take black vultures without a permit if the bird is causing death or injury to their animals. - H.R. 1897, the ESA Amendments Act, which would update the outdated ESA by establishing clear statutory definitions, focusing on species recovery, and streamlining the ESA permitting process. - S.574/H.R.1376, the Healthy Poultry Assistance and Indemnification Act, which would make all poultry growers and layer operations within a HPAI control area eligible to receive payments from APHIS compensation program, rather than only flocks that test positive. - Supported Secretary Rollins' February 2025 5 pronged approach to combat HPAI. - S.545/H.R.1266, the Combating Illicit Xylazine Act, which would schedule xylazine as a controlled substance. - H.R.845, the Pets and Livestock Protection Act, which would delist the gray wolf from the ESA to protect livestock. NEUTRAL/MONITORED BUT NOT LOBBIED BILLS: - H.R.1802, the Safeguard Pets, Animals, and Research Ethics (SPARE) Act, which would prohibit the use of animals in federally funded research, promote humane alternatives and promote ethical rehoming of retired research animals. MONARCH BUTTERFLY: - Reviewed FWS' proposal to list the Monarch Butterfly as an endangered species (Docket #: FWS-R3-ES-2024-0137-0001). - Expressed concerns to legislators over the impact this will have on agriculture. - Worked with PFB members to comply information for comments to FWS. - Attended monarch butterfly presentation at AFBF Convention. HPAI: - Had conversations with PA House and Senate offices over HPAI concerns - importance of biosecurity, education, proper compensation, preventative methods, etc. - Listened to USDA calls and other webinar addressing strategies to prevent HPAI OTHER: - Reviewed APHIS' final rule (89 FR 39194-39251) to make changes to the Horse Protection Act that would impact members involved in the equestrian industry. - Established a PA Federal Wildlife Coalition to address issues such as the ESA, Migratory Bird Treaty Act, etc. - Sent House Natural Resource's Water, Fish, and Wildlife subcommittee support letter for Endangered Species Amendments Act - Meeting with PA's APHIS Wildlife Services and PFB member regarding problems with depredation permit for predator birds - Conversations regarding protections against screwworm in Mexican cattle. Asked PA House offices to sign onto New World Screwworm letter by Rep. Gonzales.
2025 · first_quarter · Law Enforcement/Crime/Criminal Justice
Issues relating to public safety, consent decree transparency, and nationwide standards; HELPER Act (S. 978, H.R. 2094); Honoring Our Fallen Heroes Act (S. 237, H.R. 1269); Law Enforcement Officer and Firefighter Recreation Pass Act (H.R. 183); National Law Enforcement Officers Remembrance, Support, and Community Outreach Act (H.R. 309); Reauthorizing Support and Treatment for Officers in Crisis Act (S. 419); First Responders Care Expansion (FRCE) Act; The Providing Child Care for Police Officers Act; Invest to Protect Act (S. 768, H.R. 2711); LEOSA Reform Act (S. 679, H.R. 2243); Prevent Family Fire Act (H.R. 169); Thin Blue Line Act (S. 83, H.R. 378); Protect and Serve Act (S. 167, H.R. 1551); HALT Fentanyl Act (S. 331, H.R. 27); Marc Fischer Memorial Interdiction of Fentanyl in Postal Mail at Federal Prisons Act / BOP SCAN Mail Act (S. 1295, H.R. 1046); Combating Illicit Xylazine Act (S. 545, H.R. 1266); Prosecutors Need to Prosecute Act (S. 234, H.R. 350); Combating Organized Retail Crime Act (S. 1404, H.R. 2853); HIRRE Prosecutors Act; Supporting the Health and Safety of Law Enforcement Act; Crime Victims Fund Stabilization Act (H.R. 909); DRONE Act (H.R. 1058)
Client expense: Not reported · Firm income: $50,000
2025 · first_quarter · Government Issues
H.R. 1410, the "9/11 Responder and Survivor Health Funding Correction Act," a bill to amend title XXXIII of the Public Health Service Act with respect to flexibility and funding for the World Trade Center Health Program; entire bill. S. 739, the "9/11 Responder and Survivor Health Funding Correction Act," a bill to amend title XXXIII of the Public Health Service Act with respect to flexibility and funding for the World Trade Center Health Program; entire bill. H.R. 1266, the "Combating Illicit Xylazine Act," legislation to prohibit certain uses of xylazine and include xylazine as a Schedule III substance under the Controlled Substances Act; entire bill. S. 545, the "Combating Illicit Xylazine Act," legislation to prohibit certain uses of xylazine and include xylazine as a Schedule III substance under the Controlled Substances Act; entire bill. H.R. 1269, the "Honoring Our Fallen Heroes Act," a bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to provide public safety officer benefits for exposure-related cancers; entire bill. S. 237, the "Honoring Our Fallen Heroes Act," a bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to provide public safety officer benefits for exposure-related cancers; entire bill. H.R. 1726, legislation to reauthorize the Project Safe Neighborhoods grant program; entire bill. S. 1300, legislation to reauthorize the Project Safe Neighborhoods grant program; entire bill. H.R. 2240, the "Improving Law Enforcement Officer Safety and Wellness Through Data Act," legislation to require the Attorney General to develop reports relating to violent attacks against law enforcement officers; entire bill. S. 1418, the "Improving Law Enforcement Officer Safety and Wellness Through Data Act," legislation to require the Attorney General to develop reports relating to violent attacks against law enforcement officers; entire bill. S. 180, the "Protecting First Responders from Secondary Exposures Act," legislation to amend the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the use of grant amounts for providing training and resources for first responders on the use of containment devices to prevent secondary exposure to fentanyl and other potentially lethal substances, and purchasing such containment devices for use by first responders; entire bill. H.R. 621, the "Protecting First Responders from Secondary Exposures Act," legislation to amend the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the use of grant amounts for providing training and resources for first responders on the use of containment devices to prevent secondary exposure to fentanyl and other potentially lethal substances, and purchasing such containment devices for use by first responders; entire bill. S. 419, the "Reauthorizing Support for Treatment for Officers in Crisis Act," legislation to amend the Omnibus Crime Control and Safe Streets Act of 1968 to reauthorize grants to support law enforcement officers and families; entire bill. S. 560, the "EAGLES Act," legislation to reauthorize and expand the National Threat Assessment Center of the Department of Homeland Security; entire bill. H.R. 1299, the "EAGLES Act," legislation to reauthorize and expand the National Threat Assessment Center of the Department of Homeland Security; entire bill. Proposed House resolution to establish a "Bill of Rights" to support U.S. law enforcement personnel in their work to protect our communities (no resolution introduced). H.R. 32, the "No Bailout for Sanctuary Cities Act," legislation to provide that sanctuary jurisdictions that provide benefits to aliens who are present in the United States without lawful status under the immigration laws are ineligible for certain federal funds; entire bill. H.R. 2711, the "Invest to Protect Act," legislation to provide law enforcement grants for smaller departments to recruit new officers, provide retention bonuses, and allow departments to provide mental health resources for their officers; entire bill. H.R. 2654, the "Lifesaving Gear for Police Act," a bill to prohibit the enforcement of certain regulations relating to sale, donation, and transfer of federal government property to state and local law enforcement agencies; entire bill. H.R. 1046, the "Marc Fischer Memorial Act," a bill to require the Director of the Bureau of Prisons to develop and implement a strategy to interdict fentanyl and other synthetic drugs in the mail at Federal correctional facilities; entire bill. H.R. 2096, the "Protecting Our Nations Capital Emergency Act," legislation to restore the right to negotiate matters pertaining to the discipline of law enforcement officers of the District of Columbia through collective bargaining, and to restore the statute of limitations for bringing disciplinary cases against members or civilian employees of the Metropolitan Police Department of the District of Columbia; entire bill. Legislative proposal to reauthorize the Justice Department's COPS grant program (no bill introduced).
2025 · first_quarter · Pharmacy
Xylazine; Combating Illicit Xylazine Act (HR1266/S545); Controlled Substances used in veterinary medicine, Controlled Substances Act and regulations as related to veterinary medicine. Issues related to the FDA CVM.
Client expense: $215,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| NM |
| Chuck Grassley | Republican | IA |
| Cindy Hyde-Smith | Republican | MS |
| Cynthia M. Lummis | Republican | WY |
| David McCormick | Republican | PA |
| Jacky Rosen | Democratic | NV |
| James C. Justice | Republican | WV |
| James E. Risch | Republican | ID |
| James Lankford | Republican | OK |
| Jeanne Shaheen | Democratic | NH |
| Jeff Merkley | Democratic | OR |
| John Cornyn | Republican | TX |
| John Fetterman | Democratic | PA |
| Katie Boyd Britt | Republican | AL |
| Kirsten E. Gillibrand | Democratic | NY |
| Margaret Wood Hassan | Democratic | NH |
| Maria Cantwell | Democratic | WA |
| Mark Kelly | Democratic | AZ |
| Marsha Blackburn | Republican | TN |
| Michael F. Bennet | Democratic | CO |
| Mike Crapo | Republican | ID |
| Richard Blumenthal | Democratic | CT |
| Richard J. Durbin | Democratic | IL |
| Rick Scott | Republican | FL |
| Roger F. Wicker | Republican | MS |
| Ruben Gallego | Democratic | AZ |
| Shelley Moore Capito | Republican | WV |
| Ted Budd | Republican | NC |
| Ted Cruz | Republican | TX |
| Thom Tillis | Republican | NC |
| Tim Kaine | Democratic | VA |
| Todd Young | Republican | IN |
Client expense: $15,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, White House Office
Client expense: $15,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $10,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE
Client expense: $40,000 · Firm income: Not reported
Government targets: Bureau of Prisons (BOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE, White House Office
Client expense: $10,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Fish & Wildlife Service (USFWS)
Client expense: Not reported · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Fish & Wildlife Service (USFWS)
Government targets: HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), President of the U.S., SENATE
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE